Collis buys Elevance Health (ELV) shares worth $869,519

robot
Abstract generation in progress

Elevance Health Director Steven H. Collis recently acquired 3,000 shares of the company’s stock for over $869,000, noteworthy as the stock is near its 52-week low and InvestingPro analysis suggests it’s undervalued. This insider purchase comes amidst significant company news including potential Medicare Advantage sanctions, a reiterated Buy rating from TD Cowen, and a management restructuring with Peter Haytaian reportedly planning to leave.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin